Translating Molecular Signal Pathways to Orthopaedic Trauma Care
Translating Molecular Signal Pathways to Orthopaedic Trauma Care
批准号:
8709992
负责人:
Edward M. Schwarz
金额:
$145.97万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-08-15 至 2017-07-31
关键词:
AdjuvantAffectAgingAllograftingAnabolic AgentsAnatomyBone InjuryBone RegenerationCanis familiarisCellsClinicalCollaborationsDegenerative polyarthritisDiseaseElderlyEventFractureGenerationsGoalsHumanImageIn VitroIncidenceInjuryJointsManuscriptsModelingMolecularMusculoskeletalMusculoskeletal DiseasesOrthopedicsPatientsPilot ProjectsPre-Clinical ModelRecording of previous eventsResearchResearch InfrastructureResourcesRoleSignal PathwaySignal TransductionStem cellsTeriparatideTherapeuticTissuesTranslatingTranslational ResearchUniversitiesarticular cartilagebasedesigneffective therapyexperiencehuman tissuein vivoinjury and repairinnovationjoint injurymusculoskeletal injurynovelprogenitorprogramsprotective effectrepairedresearch facilityresponseskeletal injurysuccesstissue regenerationtissue repairtrauma care
中文摘要
CORT项目于2006年启动,对罗切斯特大学的肌肉骨骼研究项目产生了变革性的影响。该项目集中了一个经验丰富、才华横溢、多学科研究团队的集体努力。CORT项目的目标是将对肌肉骨骼损伤的分子、细胞和组织反应的理解转化为组织再生和修复的新疗法。CORT项目的科学基础是,损伤和修复反应从根本上依赖于干细胞祖细胞进行增殖和扩增以及随后的组织特异性分化的能力。CORT计划的统一主题是PTH是促进组织特异性MSC扩展和修复事件的关键合成代谢剂。CORT更新申请延续了一项旨在改变两种主要肌肉骨骼疾病(1)骨骼损伤和2)关节损伤/骨关节炎)治疗方法的计划。这两种疾病在老年人中发病率更高,影响更大。CORT计划刺激了科学发现,产生了61份手稿。项目1“特立帕肽治疗半月板损伤后骨关节炎”利用体内、体外临床前模型和人体组织细胞,明确甲状旁腺激素对关节软骨保护作用的机制。项目2“PTH在促进骨折修复中的作用”定义了PTH激活的下游信号和靶点,这些信号和靶点是刺激骨修复所必需的。项目3:“翻译PTH治疗作为结构同种异体移植的辅助”通过在犬模型中检查PTH在骨修复中的治疗潜力,扩大了CORT的翻译范围,并包括一项人类临床试点研究。这些项目得到了一个行政核心的支持,该核心加强了与机构CTSI和研究基地的合作和整合,以及一个创新和全面的分子和解剖成像核心。该项目具备成功所需的全部因素,包括:i)合作研究团队;Ii)一个特殊的研究基础设施,允许全面的实验方法;Iii)科学创新和致力于转化研究的历史;(四)优秀的科研团队整合并利用院校的科研资源和设施。
英文摘要
The CORT Program was initiated in 2006 and has had a transformative impact on the musculoskeletal research program at the University of Rochester. The Program has focused the collective efforts of an experienced, talented, and multi-disciplinary research team. The objective of the CORT Program is to translate understanding of the molecular, cellular and tissues responses involved in musculoskeletal injury into novel therapies for tissue regeneration and repair. The scientific basis of the CORT program is that injury and repair responses are fundamentally dependent upon the ability of stem cell progenitors to undergo proliferation and expansion, and subsequent tissue specific differentiation. The unifying theme of the CORT Program is that PTH is a key anabolic agent that promotes tissue-specific MSC expansion and repair events. The CORT renewal application continues a Program designed to transform the treatments of two major musculoskeletal diseases, 1) skeletal injury and 2) joint injury/osteoarthritis. Both diseases have a higher incidence and greater affect on the elderly. The CORT program has stimulated scientific discoveries resulting in the generation of 61 manuscripts. Project 1, "Teriparatide as a Therapy for Osteoarthritis Following Meniscal Injury" uses in vivo and in vitro preclinical models and human tissues and cells to define the mechanism involved in the chondro-protective effect of PTH on articular cartilage. Project 2, "Role of PTH in Enhancing Fracture Repair in Aging" defines the downstream signals and targets that PTH activates and which are necessary for the stimulation of bone repair. Project 3: "Translating PTH Therapy as an Adjuvant for Structural Allografting" expands the translational scope of the CORT by examining the therapeutic potential of PTH in bone repair in a canine model and includes a human clinical pilot study. The projects are supported by an Administrative Core that enhances collaborations and integration with the institutional CTSI and research base, and an innovative and comprehensive Molecular and Anatomic Imaging Core. The Program has the entire constellation of factors necessary for success, including: i) a collaborative research team; ii) an exceptional research infrastructure that permits comprehensive experimental approaches; iii) a history of scientific innovation and commitment to translational research; iv) excellent integration of and access to institutional research resources and facilities by a talented research team.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Administrative Core
-
批准号:10232834
-
项目类别:
-
资助金额:$27.7万
-
财政年份:2022
-
负责人:Edward M. Schwarz
-
依托单位:
Quantifying the Race for the Surface via IV-MLSM
-
批准号:10455337
-
项目类别:
-
资助金额:$20.33万
-
财政年份:2022
-
负责人:Edward M. Schwarz
-
依托单位:
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)
-
批准号:10232833
-
项目类别:
-
资助金额:$77.0万
-
财政年份:2022
-
负责人:Edward M. Schwarz
-
依托单位:
Quantifying the Race for the Surface via IV-MLSM
-
批准号:10618393
-
项目类别:
-
资助金额:$16.94万
-
财政年份:2022
-
负责人:Edward M. Schwarz
-
依托单位:
Rochester Resource-Based Center for Bone, Muscle and Orthopaedic Research (ROCSTARR) (Overall Application)
-
批准号:10544989
-
项目类别:
-
资助金额:$77.0万
-
财政年份:2022
-
负责人:Edward M. Schwarz
-
依托单位:
Administrative Core
-
批准号:10402964
-
项目类别:
-
资助金额:$32.13万
-
财政年份:2017
-
负责人:Edward M. Schwarz
-
依托单位:
Center of Research Translation on the Osteoimmunology of Bone Infection
-
批准号:9370633
-
项目类别:
-
资助金额:$119.48万
-
财政年份:2017
-
负责人:Edward M. Schwarz
-
依托单位:
Center of Research Translation on the Osteoimmunology of Bone Infection
-
批准号:10247748
-
项目类别:
-
资助金额:$114.0万
-
财政年份:2017
-
负责人:Edward M. Schwarz
-
依托单位:
Center of Research Translation on the Osteoimmunology of Bone Infection (CoRTOBI)
-
批准号:10402963
-
项目类别:
-
资助金额:$140.27万
-
财政年份:2017
-
负责人:Edward M. Schwarz
-
依托单位:
Defining the Protective vs. Susceptible Immune Proteome of S. aureus Osteomyelitis
-
批准号:10402967
-
项目类别:
-
资助金额:$27.45万
-
财政年份:2017
-
负责人:Edward M. Schwarz
-
依托单位:
Administrative Core
-
批准号:10247793
-
项目类别:
-
资助金额:$38.33万
-
财政年份:2017
-
负责人:Edward M. Schwarz
-
依托单位:
Project 2: Defining the Protective vs. Susceptible Immune Proteome of S. aureus Osteomyelitis
-
批准号:10247796
-
项目类别:
-
资助金额:$32.45万
-
财政年份:2017
-
负责人:Edward M. Schwarz
-
依托单位:
Overall: The University of Rochester Resource-Based Center for Musculoskeletal Biology and Medicine
-
批准号:9313204
-
项目类别:
-
资助金额:$77.0万
-
财政年份:2016
-
负责人:Edward M. Schwarz
-
依托单位:
Overall: The University of Rochester Resource-Based Center for Musculoskeletal Biology and Medicine
-
批准号:9080334
-
项目类别:
-
资助金额:$76.75万
-
财政年份:2016
-
负责人:Edward M. Schwarz
-
依托单位:
Role of B Cells in Synovial Inflammation & LN Remodeling in RA Arthritis
-
批准号:8528455
-
项目类别:
-
资助金额:$35.4万
-
财政年份:2013
-
负责人:Edward M. Schwarz
-
依托单位:
Translating PTH Therapy as an Adjuvant for Structural Allografting
-
批准号:8344380
-
项目类别:
-
资助金额:$34.96万
-
财政年份:2012
-
负责人:Edward M. Schwarz
-
依托单位:
The University of Rochester Core Center for Musculoskeletal Biology and Medicine
-
批准号:8154082
-
项目类别:
-
资助金额:$59.68万
-
财政年份:2011
-
负责人:Edward M. Schwarz
-
依托单位:
Role of B Cells in Synovial Inflammation & LN Remodeling in RA Arthritis
-
批准号:8308296
-
项目类别:
-
资助金额:$34.22万
-
财政年份:2011
-
负责人:Edward M. Schwarz
-
依托单位:
The University of Rochester Core Center for Musculoskeletal Biology and Medicine
-
批准号:8479319
-
项目类别:
-
资助金额:$57.33万
-
财政年份:2011
-
负责人:Edward M. Schwarz
-
依托单位:
The University of Rochester Core Center for Musculoskeletal Biology and Medicine
-
批准号:8314023
-
项目类别:
-
资助金额:$60.35万
-
财政年份:2011
-
负责人:Edward M. Schwarz
-
依托单位:
海外基金